UBS stuft ASTRAZENECA auf Sell
ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung für Astrazeneca auf "Sell" mit einem Kursziel von 11.300…
60,250€
-2,03%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Total Voting Rights
1 November 2024 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
AstraZeneca says its China operations president under investigation
AstraZenecas China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down…
AZN China President under investigation
This announcement contains inside information
30 October 2024
AstraZeneca China President currently under investigation
Leon Wang, Executive Vice President International and AstraZeneca China…
AstraZeneca Receives CHMPs Approval for Wainzua in Europe
The CHMP recommends approval for AZNs Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated amyloidosis.…